血清促甲状腺素及代谢指标与肥胖患者心血管疾病关系的研究现状  

Current research status on the relationship between serum thyroid-stimulating hormone and metabolic indices in obese patients and cardiovascular diseases

作　　者：李翱 王镁[2] LI Ao;WANG Mei(Liaoning university of traditional Chinese medicine,Shenyang 110847,China)

机构地区：[1]辽宁中医药大学,沈阳110847 [2]辽宁中医药大学附属医院,沈阳110033

出　　处：《中国处方药》2023年第12期189-192,共4页Journal of China Prescription Drug

摘　　要：近年来,肥胖与心血管疾病之间的关系备受关注,尤其是在肥胖患者中的甲状腺功能状态和代谢指标方面。本文深入探讨了肥胖与甲状腺功能之间的关联,包括TSH、FT4、FT3的水平与BMI的关系。研究表明,TSH升高可能与肥胖和代谢异常相关,尤其是在二级肥胖患者中。此外,TSH的升高还可能对糖代谢、尿酸水平、血压产生影响,肥胖患者的TSH升高可能导致心血管并发症的风险增加。In recent years,there has been significant attention on the intricate relationship between obesity and cardiovascular diseases,particularly concerning thyroid function and metabolic indices within obese individuals.This paper delves into an in-depth exploration of the association between obesity and thyroid function,encompassing the levels of TSH(Thyroid-Stimulating Hormone),FT4(Free Thyroxine),FT3(Free Triiodothyronine),and their correlation with BMI(Body Mass Index).The research findings suggest that elevated TSH levels may be linked to obesity and metabolic abnormalities,particularly evident among individuals with secondary obesity.Furthermore,the elevation of TSH levels may impact glucose metabolism,uric acid levels,and hypertension,potentially increasing the risk of cardiovascular complications in obese patients.

关 键 词：甲状腺激素 高血压 高尿酸 心血管并发症 

分 类 号：R589.2[医药卫生—内分泌]